Posted in | News

Holcim Indonesia Awards ThyssenKrupp Contract to Build Second Cement Plant

ThyssenKrupp Polysius has won a contract from PT Holcim Indonesia Tbk., Jakarta, to build a second cement plant near the town of Tuban on the northern coast of the island of Java. The contract is worth around 250 million US dollars and the plant is scheduled to start production in 2015.

"This follow-up order is proof of our good partnership with the customer and shows that our technological solutions and leading engineering expertise are supporting Holcim in the growth of the Indonesian cement industry. We are firmly focused on the markets of the future," says Dr. Hans Christoph Atzpodien, CEO of the Industrial Solutions business area. Indonesia is an important market and production location in Southeast Asia, and ThyssenKrupp's engineering specialists in particular have been doing business in the country for many years.

The Indonesian cement market is predicted to grow at a double-digit rate in 2013. With a production capacity of 8.2 million tons a year Holcim Indonesia is one of the country's top 3 manufacturers. The Tuban 1 plant, also being built by ThyssenKrupp Polysius, is due to begin operation in June 2013. For both plants ThyssenKrupp Polysius is supplying state-of-the-art equipment covering raw material preparation, clinker production, cement loading and fuel preparation. A POLAB laboratory automation system is being installed for quality monitoring and control. Tuban 1 and Tuban 2 will each have a capacity of 1.7 million tons of cement a year.

Source: http://www.thyssenkrupp.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.